← Back to Search

Slow Breathing for Spinal Cord Injury (SCOGA Trial)

N/A
Waitlist Available
Research Sponsored by Spaulding Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1,5 hour during slow-breathing
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how slow breathing affects heart rate & blood pressure in people with spinal cord injuries, using traditional yoga breathing exercises. #SCI #YogaBreathing

Who is the study for?
This trial is for adults aged 18-60 with spinal cord injury who are wheelchair users, have a BMI of 18.5 - 35 kg/m2, and can follow instructions. It's not for those who smoke, have irregular heartbeats, high blood pressure, take certain heart medications (except for blood pressure support), or have cancer, diabetes, epilepsy/neurological diseases, kidney disease or coronary artery disease.
What is being tested?
The study examines the effects of slow 'yogic' breathing exercises on heart rate and blood pressure in individuals with spinal cord injuries to understand its potential benefits on the cardiovascular system.
What are the potential side effects?
Since this trial involves traditional breathing exercises without medication or invasive procedures, significant side effects are not anticipated. However, participants may experience changes in their respiratory patterns.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1,5 hour during slow-breathing
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1,5 hour during slow-breathing for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Heart Rate Variability
beat-by-beat arterial pressure
beat-by-beat limb blood flow
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Spinal Cord Injury SubjectsExperimental Treatment1 Intervention
20 medically stable male and female subjects between 18 and 60 years old, BMI between 18.5-35 kg/m2, with a history of SCI and who use a wheelchair were included. Participants that did not speak English or with a history of renal, neurological, or coronary artery disease, cancer, diabetes, significant arrhythmia smoking, or using cardioactive medications were excluded.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Slow Breathing
2009
N/A
~110

Find a Location

Who is running the clinical trial?

Spaulding Rehabilitation HospitalLead Sponsor
139 Previous Clinical Trials
11,081 Total Patients Enrolled

Media Library

Spinal Cord Injury Subjects Clinical Trial Eligibility Overview. Trial Name: NCT05480618 — N/A
Spinal Cord Injury Research Study Groups: Spinal Cord Injury Subjects
Spinal Cord Injury Clinical Trial 2023: Spinal Cord Injury Subjects Highlights & Side Effects. Trial Name: NCT05480618 — N/A
Spinal Cord Injury Subjects 2023 Treatment Timeline for Medical Study. Trial Name: NCT05480618 — N/A
~6 spots leftby Nov 2025